Work

ABL kinase inhibitor increases cytotoxicity of chemotherapeutic agents while reducing/inhibiting genomic instability in multiple myeloma

Year: 2019

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.09.128

Authors: Subodh Kumar, Srikanth Talluri, Chandraditya Chakraborty, Purushothama Nanjappa, Masood Shammas, Nikhil Munshi

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980699639

FWCI:

Cites:

Cited by:

Related to: 10